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Introduction: Relatively little is known about cellular subpopulations in the mature nucleus pulposus (NP). Detailed
understanding of the ontogenetic, cellular and molecular characteristics of functional intervertebral disc (IVD) cell
populations is pivotal to the successful development of cell replacement therapies and IVD regeneration. In this
study, we aimed to investigate whether phenotypically distinct clonal cell lines representing different
subpopulations in the human NP could be generated using immortalization strategies.
Methods: Nondegenerate healthy disc material (age range, 8 to 15 years) was obtained as surplus surgical material.
Early passage NP monolayer cell cultures were initially characterized using a recently established NP marker set. NP
cells were immortalized by simian virus 40 large T antigen (SV40LTag) and human telomerase reverse transcriptase
expression. Immortalized cells were clonally expanded and characterized based on collagen type I, collagen type II,
α1 (COL2A1), and SRY-box 9 (SOX9) protein expression profiles, as well as on expression of a subset of established
in vivo NP cell lineage markers.
Results: A total of 54 immortal clones were generated. Profiling of a set of novel NP markers (CD24, CA12, PAX1,
PTN, FOXF1 and KRT19 mRNA) in a representative set of subclones substantiated successful immortalization of
multiple cellular subpopulations from primary isolates and confirmed their NP origin and/or phenotype. We were
able to identify two predominant clonal NP subtypes based on their morphological characteristics and their ability
to induce SOX9 and COL2A1 under conventional differentiation conditions. In addition, cluster of differentiation
24 (CD24)–negative NP responder clones formed spheroid structures in various culture systems, suggesting the
preservation of a more immature phenotype compared to CD24-positive nonresponder clones.
Conclusions: Here we report the generation of clonal NP cell lines from nondegenerate human IVD tissue and
present a detailed characterization of NP cellular subpopulations. Differential cell surface marker expression and
divergent responses to differentiation conditions suggest that the NP subtypes may correspond to distinct maturation
stages and represent distinct NP cell subpopulations. Hence, we provide evidence that the immortalization strategy
that we applied is capable of detecting cell heterogeneity in the NP. Our cell lines yield novel insights into NP biology
and provide promising new tools for studies of IVD development, cell function and disease.Introduction
Degenerative disc disease (DDD) poses a substantial so-
cioeconomic burden in developed countries [1]. Cur-
rently, treatment of DDD is primarily aimed at relieving
symptoms because effective therapy to delay or prevent
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article, unless otherwise stated.The intervertebral disc (IVD) consists of a central gelat-
inous nucleus pulposus (NP) encircled by an elastic, liga-
mentous annulus fibrosus (AF) and is flanked superiorly
and inferiorly by cartilaginous endplates. NP cells are
highly specialized and share some features with articular
chondrocytes in terms of aggrecan (ACAN), collagen type
II, α1 (COL2A1), and SRY-box 9 (SOX9) protein expres-
sion [2]. However, compared to articular cartilage (AC),
the NP maintains a unique extracellular matrix (ECM)
with a higher glycosaminoglycan to hydroxyproline (GAG/
OH-pro) ratio, and its native cells display distinctive geneCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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relate with reduced cellularity, aberrant cell function, loss
of proteoglycans and concomitant tissue dehydration [6].
As cells within the IVD are responsible for ECM mainten-
ance and homeostasis, they play an important role in the
degenerative process. The findings in an increasing num-
ber of studies support the idea that mature NP cells are
derived from precursor notochordal cells (NCs), although
NP cells differ from NCs morphologically and express dif-
ferent genes (reviewed in [7]). However, it is becoming in-
creasingly clear that the NP comprises multiple cell
subpopulations [8-11]. This cellular heterogeneity may re-
flect different stages of proliferation, differentiation and
maturation; however, relatively little is known about these
NP cell subpopulations. Successful development of cell
replacement therapies and IVD regeneration is crucially
dependent on an in-depth understanding of cellular and
molecular characteristics of the functional IVD. To accom-
plish this, access to representative human cell models is
pivotal. However, current research on primary cells is ham-
pered by restricted availability of human cells, particularly
from nondegenerate discs, where there is a relatively inher-
ent low cellularity within the tissue. In addition, lack of
well-defined cellular characteristics and differences in the
origin of study material (for example, donor age, IVD de-
generation status) underlies experimental variability and
thus low reproducibility. To date, a few NP cell lines have
been independently generated by Sakai et al. [12] and,
more recently, by Liu and co-workers [13].
As no cell lines are available that represent the re-
ported different subpopulations in adult human NP cells,
we set out to generate in vitro cell models for human
NP cells. Our approach using immortalization, clonal se-
lection and outgrowth allowed us to address NP cell het-
erogeneity. Here we provide a molecular and cellular
characterization of the first immortal human NP cellular
subpopulations.
Methods
Isolation of intervertebral disc cells, cell culture and
immortalization
Nondegenerate healthy disc material was obtained as sur-
plus material from correction surgery (Maastricht University
Medical Centre Medical Ethical Review Committee (MERC)
approval 08-4-028). Under Dutch law, informed patient
consent is part of the MERC approval and is not required
separately (see Table 1). Determination of the absence of
DDD was based on macroscopic examination. Tissue
samples were macroscopically dissected by the staff
surgeon. Only IVD tissue from the convex side of the
scoliotic disc was used for processing. To prevent cross-
contamination between IVD-derived tissues, remnant
endplate material was completely resected and a broad
section of the transition zone extending well into definedNP tissue or outer AF tissue was removed. NP and AF tis-
sues were stored and processed separately. Tissue was dis-
sected into small pieces and digested overnight with 0.05%
collagenase type II (17101-015; Invitrogen, Carlsbad, CA,
USA) in Dulbecco’s modified Eagle’s medium/Nutrient
Mixture F-12 (GlutaMAX DMEM/F-12; Gibco, Grand
Island, NY, USA) buffered with 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid at 37°C under constant agi-
tation. Isolates were passed through a 70-μm cell strainer
and collected by centrifugation (280 × g, 5 minutes, Eppen-
dorf centrifuge 5810R) and cultured in maintenance
medium (Mmed) (DMEM-F-12/GlutaMAX, 10% foetal calf
serum (DE14-801 F; BioWhittaker, Walkersville, MD,
USA), 1% penicillin-streptomycin (Gibco) and 1% nones-
sential amino acids (NEAAs) (Gibco). Cells were seeded at
a density of 30,000 cells/cm2. Upon confluence (passage 0
(P0)), cultures were expanded as pools (1:2 dilutions per
passage, until P5) to obtain sufficient material for initial
characterization. Monolayer differentiation was induced
using an established protocol for articular chondrocytes
[14]. A total of 30,000 cells/cm2 were incubated in dif-
ferentiation medium (Dmed: DMEM/F-12, 1% antibiotic/
antimycotic, 1% insulin/transferrin/sodium selenite (ITS;
Invitrogen)), 1% L-ascorbic acid 2-phosphate deoxycho-
late (Sigma-Aldrich, St Louis, MO, USA), 1 ng/ml trans-
forming growth factor β3 (TGFβ3) (PHG9305; Gibco)
and 1% NEAA for the indicated time periods. The U-
CH1 chordoma cell line (courtesy of S Brüderlein, Ulm,
Germany) was grown as previously described [15].Retroviral transduction and generation of immortal clones
The simian virus 40 large T antigen (SV40LTag) and hu-
man telomerase reverse transcriptase (hTERT) cDNAs
were cloned into pBABE-hygro [16] and pBMN-IRES-
NEO vectors, respectively. Production of viral particles
was performed as described previously [17]. Viral titres
were sufficiently high to achieve nearly 100% infection.
Retrovirally transduced P5 AF and NP cells from do-
nors 4 and 5 were selected with 400 μg/ml G418 and
25 μg/ml hygromycin B (PAA Laboratories/GE Health-
care Life Sciences, Somerset, UK). Immediately follow-
ing selection, clones were generated by plating less than
1 cell (that is, ±0.5) per well in 96-well plates in reduced
selection medium (200 μg/ml G418 and 12 μg/ml
hygromycin B). After 1 week of culture, small colonies
became discernible. Culture wells with more than one
colony were omitted from further study to ensure single
picks. Single clones were expanded under continued
antibiotic selection pressure and expanded for three
more passages (P1 to P4) for cryogenic storage and
screening experiments. Selected clones were expanded
and remained stable for 8 months or 328 additional
population doublings.
Table 1 Intervertebral disc donor characteristics and clonesa
Morphology
Donor Sex Ageb, yr Medical indication Position IVD T mRNA primary isolates NP clones Wave Cobbl Tiny
D1 M 8 Spina bifida/scoliosis T11-L4 Positive N/A
D2 F 13 Idiopathic scoliosis L1-L4 Negative N/A
D3 M 14 Spina bifida/scoliosis T12-L4 Negative N/A
D4 F 15 Idiopathic scoliosis T7-T10 Negative 34 19 14 1
D5 M 13 Spina bifida/scoliosis T6-L1 Negative 20 11 7 2
aIVD, Intervertebral disc; L, Lumbar; N/A, Not applicable; NP, Nucleus pulposus; T, Thoracic. bAge in years at the time discs were obtained during surgery. Tissues
were obtained from young adolescent scoliosis patients who had undergone correction surgery. In contrast to herniated or adult discs, these intervertebral discs
showed no signs of degeneration; they had clear, lucid nuclei pulposi that could easily be distinguished from the annulus fibrosis. Each cell isolate (from donors
D1 to D5) derived from AF and NP tissue excised at multiple adjacent levels, ranging from T6 to L4 as indicated, in a single individual. The total number of
generated clones is indicated in column ‘Immortal NP clones’, and the amount of cobblestone (Cobbl), wavelike (Wave) and tiny clones is indicated in column
‘Clonal morphology’. Brachyury T (T) expression was measured in all primary isolates at the mRNA and protein levels; only D1 was found to be positive.
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To measure TERT activity, a telomeric repeat amplifica-
tion protocol assay was performed according to the
manufacturer’s instructions (TRAPeze Telomerase De-
tection Kit; Millipore, Amsterdam, the Netherlands)
[18]. Briefly, 1 μg of total protein input was used to pro-
duce tandem TAAGGG repeats (extension step at 30°C
for 30 minutes); these repeats were amplified by PCR
using telomere-specific primers (30 cycles), which typic-
ally generated a ladder of products with 6-bp increments
starting at 50 nucleotides (for example, 50, 56, 62, 68).Aggrecan coating differentiation assays
To assess NP clonal responses to a relevant proteoglycan
in the NP ECM, ACAN was used to coat culture dishes.
In brief, we added 5 μg of purified bovine ACAN
(Sigma-Aldrich A1960) in 200 μl of solution to 24-well
culture plates. The continuously agitated solution was
allowed to evaporate overnight at ambient temperature
under sterile conditions as described previously [19].
Plates were washed twice with phosphate-buffered saline
(PBS), and 200,000 cells/well suspended in Dmed were
seeded. Media were changed every other day.Matrigel cell culture assays
To assess increases in NP clonal behaviour in a three-
dimensional environment, we established a Matrigel
hydrogel system to support chondrogenesis of articular
chondrocytes. Briefly, 90 μl of growth factor–reduced
Matrigel (BD Biosciences, San Jose, CA, USA) was dis-
pensed into 12-well culture plates (Greiner Bio-One,
Monroe, NC, USA). NP cells (N = 68,400) were grown for
7 days under conventional (that is, articular chondrocyte)
differentiation conditions (in Dmed). mRNA samples were
taken at 7 days and isolated using the mirVana mRNA
Isolation Kit (Ambion, Austin, TX, USA) for whole RNA
extraction according to the manufacturer’s instructions.RNA isolation and quantitative real-time PCR
For RNA isolation, cells were disrupted in TRIzol reagent
(Invitrogen). RNA isolation, RNA quantification (UV) spec-
trometry (Nanodrop, Thermo Scientific) and cDNA synthe-
sis were performed as described before [20]. Real-time
quantitative PCR (RT-qPCR) was performed using Mesa-
green qPCR MasterMix Plus for SYBR Green (Eurogentec).
Validated primer sets used are depicted in Table 2. An
Applied Biosystems ABI PRISM 7700 Sequence Detection
System was used for amplification achieved by initial de-
naturation 95°C for 10 minutes followed by 40 cycles of
DNA amplification. Data were analysed using the standard
curve method and normalized to β-actin (bACT).
Protein extraction and immunoblotting
Protein extraction and immunoblotting were performed
and analysed as described previously with minor adjust-
ments [21]. For extraction, cells were lysed in radioimmu-
noprecipitation assay buffer (50 mM Tris, pH 8.0, 150 mM
NaCl, 0.1% SDS, 5 mM ethylenediaminetetraacetic acid
(EDTA), 0.5% w/v sodium deoxycholate and 1% Nonidet
P-40) supplemented with protease and phosphatase inhibi-
tors (Roche Diagnostics, Indianapolis, IN, USA). Lysates
were sonicated on ice using the Soniprep 150 Plus ultra-
sonic disintegrator (MSE, London, UK) at amplitude 10 for
14 cycles (1 second on, 1 second off). Insoluble material
was removed by centrifugation (10 minutes at 16,000 × g
and 4°C). Protein concentration was determined using a
bicinchoninic acid protein assay kit (Pierce/Thermo Scien-
tific, Rockford, IL, USA). Protein samples were separated
by SDS-PAGE and immobilized on nitrocellulose mem-
branes. Membranes were blocked for 1 hour in 5% nonfat
dry milk powder (FrieslandCampina, Amersfoort, the
Netherlands) at ambient temperature and then incubated
with primary antibodies overnight at 4°C. Antisera used
were polyclonal goat anti-COL2A1 (1320-01; Southern
Biotech, Birmingham, AL, USA), polyclonal goat collagen
type I, α1 (anti-COL1A1) (1310-01; SouthernBiotech),
Table 2 Quantitative PCR primer lista
Symbol Gene name Tissue Forward primer Reverse primer
ACAN Aggrecan AC, NP GCAGCTGGGCGTTGTCA TGAGTACAGGAGGCTTGAGGACT
CA12 Carbonic anhydrase XII NP ATCCAACTAATGCCACCACCAA TGAGACCACGAAGAGACTGGCT
COL1A1 Collagen type I, collagen α1 AF TGGAGAGTACTGGATTGACCCC TGCAGAAGACTTTGATGGCATC
COL2A1 Collagen type II, collagen α1 AC, NP TGGGTGTTCTATTTATTTATTGTCTTCCT GCGTTGGACTCACACCAGTTAGT
COMP Cartilage oligomeric matrix protein AC CAAGGCCAACAAGCAGGTTTG CAGTTATGTTGCCCGGTCTCA
CD24 Cluster of differentiation 24 NP CCACGCAGATTTATTCCAGTGA GCCAACCCAGAGTTGGAAGTAC
FOXF1 Forkhead box F1 NP CCCACACAGGAATTCTGCTGA TTCCCCCACTTCTGCCATT
KRT19 Keratin 19 NC, NP GCAGTCACAGCTGAGCATGAA TCCGTTTCTGCCAGTGTGTCT
PAX1 Paired box 1 NP AGAGCCTGACATCGCCTGTTAA CGCTTTCCTTTATTCAGAGGCA
PTN Pleiotrophin NP AGAAGCAATTTGGCGCGGA TTCAGGTCACATTCTCCCCAGG
SOX9 SRY-box 9 AC, NP AGTACCCGCACCTGCACAAC CGCTTCTCGCTCTCGTTCAG
T Brachyury T NC CCACCTGCAAATCCTCATCCT TTGGAGAATTGTTCCGATGAGC
aAC, Articular cartilage; AF: Annulus fibrosus; NC, Notochordal cell; NP, Nucleus pulposus. The sequences are the validated real-time primer sets used for the
indicated genes that were subjected to quantitative PCR analysis. ‘Tissue’ column lists tissue in which marker expression is reported.
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UK), rabbit polyclonal antibody against brachyury T (here-
after ‘T’) (H-210 and SC-20109; Santa Cruz Biotechnology,
Santa Cruz, CA, USA), mouse monoclonal anti-SV40LTag
(Pab 108, sc-148; Santa Cruz Biotechnology), rabbit poly-
clonal anti-TERT (R1187; Acris Antibodies, San Diego, CA,
USA), mouse monoclonal β-actin (clone C4, 08691001; MP
Biomedicals, Santa Ana, CA, USA), mouse monoclonal
α-tubulin (clone B-5-1-2, T6074; Sigma-Aldrich), rabbit poly-
clonal KAP-1 (A300-275A; Bethyl Laboratories, Montgomery,
TX, USA). Secondary antisera used were polyclonal rabbit
anti-goat (P0449; Dako Cytomation, Glostrup, Denmark),
rabbit anti-mouse (P0260; Dako) and donkey anti-rabbit
(711-035-152; Jackson ImmunoResearch Laboratories, West
Grove, PA, USA). Signals were detected using enhanced
chemiluminescence (Pierce/Thermo Scientific).
Flow cytometry
Flow cytometry was performed as described previously
[22]. Cell surface markers analysed were cluster of differ-
entiation 44 (CD44), CD73, CD90 and CD105 (Miltenyi
Biotec, San Diego, CA, USA); gangliosidase 2 (GD2)
(Santa Cruz Biotechnology); and CD24 (BioLegend, San
Diego, CA, USA). Briefly, antibody incubation (10 minutes
at 4°C in the dark) was followed by washes.
Cell proliferation assays
Cells were seeded at 6,400 cells/cm2, allowed to attach over-
night (t0; baseline) and grown in 12-well plates for 12 days.
At the indicated time points (cf. Figure 2C), cells were
washed in PBS, fixed in 3.7% formaldehyde in PBS solution
for 10 minutes at ambient temperature and rinsed with
demineralized water. Nuclear DNA was stained (0.1%
Crystal violet, 30 minutes, ambient temperature), afterwhich cells were washed extensively with demineralized
water. Crystal violet was extracted at a fixed volume of
10% acetic acid. Absorbance was determined at 590 nm
(Benchmark microplate reader; Bio-Rad Laboratories,
Hercules, CA, USA).
Biochemical matrix assays
Total sulphated GAG content was determined in papain-
digested samples by using 1,9-dimethylmethylene blue
stain (DMB) (Polysciences, Eppelheim, Germany) [23].
Briefly, cell cultures were washed with 0.9% NaCl and in-
cubated at 60°C for 16 hours in digestion buffer (100 mM
sodium phosphate, pH 6.5, 5 mM L-cysteine HCl, 5 mM
EDTA) containing 125 to 140 μg/ml papain (Sigma-Al-
drich P3125). Samples were collected and centrifuged at
12,000 rpm for 5 minutes, and the supernatants were incu-
bated with DMB solution (46 μM DMB, 40.5 mM glycine,
40.5 mM NaCl, pH 1.5). An absorption ratio of 540 nm/
595 nm was determined within 5 to 10 minutes of adding
DMB solution. A standard curve of chondroitin sulphate
(Sigma-Aldrich) was included as a reference. OH-pro
quantification was performed using a chloramine-T assay
and compared to a trans-4-hydroxyproline standard essen-
tially as described previously [24]. Both GAG and OH-pro
content were normalized against cellular DNA content.
DNA concentration in papain-digested samples was deter-
mined using SYBR Green stain (Eurogentec, Fremont, CA,
USA) as described previously [14]. Quantification of DNA
concentration was analysed against a genomic control
DNA standard (calf thymus; Invitrogen).
Statistics
Statistical significance (P < 0.05) was determined by two-
tailed Student’s t-test. To test for normal distribution of
van den Akker et al. Arthritis Research & Therapy 2014, 16:R135 Page 5 of 16
http://arthritis-research.com/content/16/3/R135input data, D’Agostino–Pearson omnibus normality tests
were performed. All quantitative data sets presented
passed the normality tests. The results of gene expres-
sion analyses are reported as means with standard devia-
tions where indicated. The P-values given in the figure
legends are for comparisons between AF and NP for all
donors combined or between clonal subtypes (NP-R vs
NP-nR). P-values for every statistical calculation are pre-
sented in Additional file 1: Tables S1 to S4.
Results
Phenotypic characterization of primary nucleus pulposus
cultures
Isolated primary NP cells have been reported to display
a rounded morphology and AF cells a comparatively
more elongated morphology [25,26]. As immortalization
procedures and isolation and expansion of cell clones re-
quire cells to be adherent, we adapted culture conditions
to a monolayer system. Under these adherent growth
conditions, primary NP and AF cells both showed a
spread-out morphology at early passages (Figure 1A). To
validate their NP and AF phenotypes (and hence their
tissue origin), we analysed a number of independent pri-
mary NP cultures (donors 1 to 5; see Table 1) at different
passages for protein and mRNA marker expression
(Table 2) and compared them to complementary AF cul-
tures (Figures 1B and 1D to 1F). Primary cultures from
two independent donors, D1 (P0) and D2 (P1), showed
more prominent COL2A1 mRNA expression in NP cul-
tures and expressed COL1A1 equally in NP and AF cul-
tures (Figure 1B). COL2A1 protein was detectable in
one of two low-passage NP isolates, but not in primary
AF cells (Figure 1B). COL1A1 protein was clearly detect-
able in all AF cultures, but was considerably lower in
primary NP cells. These findings are consistent with re-
ported differences between AF and NP cells [27].
Cell isolates D4 and D5 were expanded to P5 for com-
parative analysis and cloning (Figure 1C). The chondro-
cyte phenotype is known to be unstable in vitro [28,29].
We therefore tested the differentiation capacity of primary
IVD cell cultures. AF and NP cell isolates (P5) from two
independent donors showed low amounts of COL2A1
and comparable COL1A1 protein levels (Figure 1D).
Dmed induced SOX9 protein expression in primary NP
and AF cultures (Figure 1E). In addition, COL2A1 was in-
duced in Dmed in NP as well as AF isolates. Importantly,
COL2A1 induction was clearly more prominent in NP
cultures (Figure 1E), whereas COL1A1 expression was
higher in AF cells (Figure 1E).
NP marker mRNA analysis for CA12, CD24, FOXF1,
PAX1, PTN and cytokeratin 19 (KRT19) clearly discrimi-
nated between AF and NP cultures in samples from three
independent donors (Figure 1F). KRT19 mRNA was
higher in NP compared to AF cultures (4- to 70-fold), aswere CA12 (1.5- to 3-fold), CD24 (2- to 2.5-fold), FOXF1
(1.9- to 2.3-fold), PAX1 (1.2- to 15-fold) and PTN (2- to
3-fold). These six markers initially appeared stable in
pools P0 to P5, although expression diminished thereafter,
at P10 (data not shown). Of note, neither T mRNA nor
protein was detected in the primary NP isolates of the do-
nors, except for the youngest donor (D1, age 8 years)
(Table 1). T is specifically expressed in the notochord and
in NCs in the IVD. As such, this finding suggests that the
primary isolates that we used for cell line generation were
free of NCs. These combined phenotypic analyses con-
firmed the respective tissues of origin of the primary NP
and AF cell isolates and suggest that differentiation cap-
acity was maintained in primary NP cultures. Taken to-
gether, these findings provide a solid basis for experimental
immortalization and clonal cell line generation.
Isolates from two different donors (D4 and D5) (Table 1)
were immortalized at P5 using a combination of retroviral
vectors expressing SV40LTag or hTERT. SV40LTag and
hTERT expression and/or function were analysed in trans-
duced AF and NP pools (Figures 2A and 2B). Assessment
of the proliferative capacity of transduced AF and NP
pools revealed that proliferation lifespan was extended
well beyond that of the nonimmortalized parental cell
pool (Figure 2C). Transduced, G418-resistant AF and
NP cells were seeded at low density to allow expansion
of single immortal colonies. A more detailed description
of the procedure is provided in the Methods section. A
detailed characterization of immortal AF clones will be
published elsewhere.
Immortal NP clones from each donor exhibited a set of
distinct morphologies. During monolayer expansion, 40%
(D4) and 35% (D5) of the clones showed a ‘cobblestone’
appearance and 56% (D4) and 55% (D5) were organized in
wavelike patterns (Figures 3A and 3B and Table 1). A
third, rare clonal phenotype consisted of distinctly smaller
cells, denoted as ‘tiny (3% of D4 clones and 10% of D5
clones) (Figures 3A and 3B). Stimulation with Dmed fur-
ther emphasized the differences in morphology (Figure 3B,
bottom panel). Very low T mRNA expression (on average
100-fold lower than the U-CH1 positive control), and
absence of T protein indicated that representative clones
expressed few if any notochord markers (Figure 3C). The
observation that these phenotypic subtypes could be estab-
lished from two independent donor NP pools strongly
suggests that multiple different cell phenotypes coexist in
the human NP and that these can be isolated as NP sub-
types and propagated as immortal cell lines.
Phenotypic characterization of immortalized nucleus
pulposus clones
We next examined the differentiation capacity of 20 indi-
vidual immortalized D5 NP clones (Table 1). Expanded












































































































Figure 1 Confirmation of the nucleus pulposus cell phenotype in vitro. (A) Representative phase-contrast images of primary nucleus pulposus
(NP) and annular fibrosus (AF) cells from donor 1 (D1) and donor 2 (D2). Passage numbers (Px) for each donor’s tissue are indicated in parentheses
(for example, D1 (P0)). Black bars = 20 μm. (B) Top: Graphed results of gene expression analysis of the chondrocyte markers collagen type I, α1 (COL1A1),
and collagen type II, α1 (COL2A1), in primary AF (white bars) and NP (black bars) cell isolates from D1 (P0) and D2 (P1) tissues, respectively. Gene
expression was normalized to β-actin (bACT) mRNA levels. Data presented are relative to the AF values. Lower panels: Immunoblot analysis of
primary AF and NP cell lysates from two independent donors, D1 (P0) and D3 (P1), respectively, for COL1A1 and COL2A1. bACT was used as a
loading control. (C) Representative phase-contrast images of AF and NP cultures from D4 and D5, both at P5. Black bars = 20 μm. (D) Immunoblot
analysis of COL1A1, COL2A1 and SRY-box 9 (SOX9) on cell lysates from P5 AF and NP cells. (E) P5 AF and NP cells were stimulated for 7 days with
differentiation medium, and cell lysates were analysed for COL1A1, COL2A1 and SOX9. bACT was used as a loading control. (F) Gene expression
(mRNA) analysis of six NP markers: keratin 19 (KRT19), Carbonic anhydrase XII (CA12), cluster of differentiation 24 (CD24), Forkhead box F1 (FoxF1),
paired box 1 (Pax1) and pleiotrophin (PTN) in cultured AF (white bars) and NP cell isolates (black bars) in tissue from three independent donors: D2
(P1), D4 (P5) and D5 (P5). Marker gene expression was normalized to bACT levels. NP data presented are relative to AF values (per patient). aIndicated
P-values were obtained by comparing AF and NP values combined for all three donors. Statistical significance was assessed by Student’s t-test.
*P < 0.05; **P < 0.01. P-values for AF vs NP comparisons per donor are listed in Additional file 1: Table S1.
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at the level of proteins (SOX9, COL2A1 and COL1A1).
The majority (90%) of clones displayed one of two re-
sponses based on their ability to undergo chondrogenic dif-
ferentiation: responder NP (NP-R) clones showed a clear
differentiation-dependent induction of SOX9 expression,
whereas nonresponder (NP-nR) clones did not (Figure 4A).
In NP-R clones, SOX9 induction correlated with COL2A1
induction, whereas this was not the case for NP-nR
clones, which expressed higher basal COL2A1 levels at t0)than NP-R clones. COL1A1 protein was detectable in
most clones in Mmed and relatively increased in NP-R
clones in Dmed compared to NP-nR clones. Of note,
the induction profiles correlated perfectly with clonal
morphology: All chondrogenic NP-R clones exhibited the
wavelike morphology, whereas all NP-nR clones displayed
a cobblestone appearance (Figure 4A, lower panels). As
the ‘tiny’ clone morphology did not show a consistent







































































































































Proliferation (days)2 3 4 52 3 41 61
2 3 41
2 3 4 5 61
Figure 2 Immortalization by retroviral transduction. (A) Immunoblot analysis of human telomerase reverse transcriptase (hTERT), simian virus
40 large T antigen (SV40LTag) and P53 expression in cell lysates from mortal and immortal cells at extended culture periods (passage 20 (P20) for
mortal and P40 for immortal cells). Cells were immortalized at P5. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a loading
control. (B) Telomeric repeat amplification protocol assay demonstrating telomerase activity in immortalized donor 4 (D4) and D5 annulus fibrosus
(AF) and nucleosus pulposus (NP) cells (lanes 4 and 6, respectively) compared to control cultures (primary cultures (P5), lanes 3 and 5). Lanes 1 and 2
represent positive controls for PCR amplification (TSR8 oligonucleotide synthesis reagent in the TRAPeze kit) and TERT, respectively. Lane numbers are
indicated below the images. Fragment size is indicated in base pairs (bp). #Internal PCR standard. *Aspecific PCR products. (C) Spectrometric quantification
of Crystal violet staining assays reflecting relative proliferation of immortalized and primary cells at each indicated time point (compared to baseline (t= 0)).
P20 cultured primary cells had a negligible proliferative index as they approached 50 population doublings (PDLs). The immortalized cells had undergone
approximately 160 PDLs (corresponding to ±40 passages) postimmortalization at this time point. hT/LT denotes cells transduced with hTERT (hT) and
SV40LTag (LT).
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above could discriminate between the clonal subtypes
(NP-R vs nR), we evaluated differences in mRNA levels of
KRT19, CA12, CD24, PTN, FOXF1 and PAX1. In addition,
we included cartilage oligomeric matrix protein (COMP),
a gene previously shown to be expressed in rat AC and
NP cells and in human NP cells [30,31]. Comparative gene
expression analysis of two groups of six representative
chondrogenic NP-R and NP-nR clones revealed a clear
segregation between the two subtypes. Of these markers,
CA12 and FOXF1 levels were significantly higher at t0 in
NP-R clones (Figure 4B; see Additional file 1: Table S2).
CD24 showed a trend towards lower expression in NP-R
clones under maintenance conditions, whereas COMP
mRNA levels tended to be higher in this NP subtype
under the same conditions; however, these differences
did not reach significance (P = 0.056 and P = 0.099,respectively). KRT19, PAX1 and PTN mRNA levels were
not significantly different between NP-R and nR clones at
t0. Exposing NP subtypes to differentiation conditions in-
duced distinct responses (that is, marker gene expression)
between the NP subtypes. CA12 mRNA levels significantly
decreased in both NP-R and NP-nR clones, which elimi-
nated the original differences (that is, at t0) between these
subtypes (7 days in Dmed) (Figure 4B). In contrast, FOXF1
and COMP significantly changed in NP-R clones, but not
in NP-nR clones, in Dmed. Conversely, PAX1 levels sig-
nificantly dropped in NP-nR clones, but not in NP-R
clones, in Dmed. Remarkably, all seven markers tested
displayed enhanced differences in expression levels in
NP-R versus NP-nR clones under Dmed conditions, three
of which reached significance (FOXF1 (P = 0.008), PTN
(P = 0.01) and COMP (P = 0.02)). The remaining four
markers showed consistent trends (CA12 (P = 0.069), CD24
Figure 3 Clonal phenotype of nucleus pulposus cell lines. (A) Representative phase-contrast images of cobblestone, wavelike and tiny cell
morphology of immortalized donor 4 (D4) nucleus pulposus (NP) cells. (B) Representative phase-contrast images of cobblestone, wave-like and
tiny cell morphology of immortalized D5 NP cells. Images were captured upon confluence in maintenance or differentiation medium. The
percentage of the total amount of clones per phenotype is indicated below the images. Black bars in = 20 μm. (C) Scatterplot (top) of relative
Brachyury T expression levels in immortalized NP clones. The horizontal bar represents the average T mRNA level of all six NP clones represented
in the immunoblot images (bottom), which show T protein levels in NP clones. Each data point represents a triplicate measurement for an
individual clone. The solid black bars represent the averages associated with specific clonal morphology. The dashed bar represents the average
of six clones combined. The U-CH1 cell line was used as a positive reference for both mRNA and protein expression analyses.
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(Figure 4B). CD24 excepted, expression of all markers
was reduced in NP-nR clones under these conditions.
The induction of important ECM structural protein-
encoding mRNAs such as COL2A1 and ACAN was rela-
tively low at the transcriptional level and did not correlate
with cell morphology (data not shown).
In summary, the results of our analyses demonstrate
clear differentiation-induced COL2A1 and SOX9 protein
detection in NP-R clones that correlate well with the de-
scribed morphological characteristics. The phenotypic
differences between NP-R and NP-nR clones are further
substantiated by differential NP marker gene expression
profiles, under both nondifferentiation and differenti-
ation conditions, and suggest functional phenotypic dif-
ferences between the immortalized clonal subtypes.Cell surface characterization of nucleus pulposus clones
On the basis of the differential marker expression profiles,
we hypothesized that NP-R clones represent a NP stem
cell progenitor-like phenotype, whereas the NP-nR clones
might have been immortalized at a more advanced differ-
entiation or maturation stage. To obtain further support
for this supposition, we analysed a number of mesenchy-
mal stem cell (MSC) surface markers (CD73, CD90 and
CD105), a disc progenitor marker (GD2) and ontogeny
markers (cell adhesion glycoprotein CD24, chondrocytic
hyaluronan and collagen receptor CD44) [32-36]. We se-
lected a number of NP-R and NP-nR clones for flow cy-
tometry analysis based on (1) highest SOX9 and COL2A1
protein expression and (2) fold difference in basal KRT19,
FOXF1 and CA12 gene expression levels (see Figure 4).
We used the cell line U-CH1 was used as a reference [15].
Figure 4 Marker expression in clonal subtypes. (A) Immunoblot analyses of collagen type II, α1 (COL2A1), SOX9 and collagen type II, α1
(COL1A1), in responder nucleus pulposus (NP-R) clones (left panels) and nonresponder nucleus pulposus (NP-nR) clones (right panels). Cell clones
were incubated for 7 days with differentiation medium (Dmed; ‘D’ in figure) or maintenance medium (Mmed; ‘M’ in figure). The different subtype
samples were run on the same gels to enable direct quantitative comparison. Three representative clones per NP subtype are shown. β-actin
(bACT) was used as a loading control. Representative phase-contrast images of NP-R clones 108, 114 and 115 and of NP-nR clones 105, 113 and
119 are shown in the bottom row. Black bars = 20 μm. (B) (top right panel; continued in lower panels) Scatterplots of relative gene expression
analysis of keratin 19 KRT19, Carbonic anhydrase XII (CA12), cluster of differentiation 24 (CD24), Forkhead box F1 (FOXF1), paired box 1 (PAX1), pleiotrophin
(PTN) and cartilage oligomeric matrix protein (COMP) in six representative NP-R clones (104, 108, 114, 115, 121 and 124; grey symbols) and six representative
NP-nR clones (102, 105, 110, 113, 116 and 119; black symbols) at baseline (t0) (Mmed) or at 7 days of culture in Dmed. Gene expression was normalized to
bACT mRNA levels. Log2-scaled expression data are presented relative to the average expression level of NP-nR at t0. Each data point represents a triplicate
measurement for an individual clone. The P-values were obtained by comparing the indicated experimental groups. Statistical significance was assessed by
Student’s t-test. *P< 0.05; **P< 0.01. Full list of P-values is available in Additional file 1: Table S2.
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surface expression was most prominent in NP-nR
clones and suggested a more advanced maturation stage
(Figures 5A and 5B) [10]. Both NP subtypes were CD44+
(Figure 5C). In good correlation with their presumed more
advanced differentiation stage, NP-nR clones showed more
prominent GD2 positivity than NP-R clones under both
basal conditions and differentiation conditions Figure 5D)
[10]. Both NP clonal subtypes were CD90+/CD105+/CD73+
for these markers (Figure 5C). The observation that all cells
were positive for one of the markers in a marker cocktail
(CD14, CD20, CD34 and CD45) (data not shown) supportsthe argument that neither clonal subtype displayed pure
MSC properties. Combined, however, the CD marker ex-
pression profiles of the NP subtypes do support a mesen-
chymal origin of the immortal NP clones. Moreover, the
CD24/GD2 status discriminates between the NP-R and
NP-nR subclones and suggests a difference in differenti-
ation or maturation stage.
Extracellular matrix molecules in nucleus pulposus cell
differentiation
The ECM provides a biological niche that plays a signifi-
cant role in cellular responses and, as such, in tissue
Figure 5 Cell surface characterization of nucleus pulposus clones. (A) Cluster of differentiation 24 (CD24) histograms (top panels; green) of
representative responsive and nonresponsive nucleosus pulposus (NP-R and NP-nR, respectively) subtypes (NP-R115 and NP-nR105) and an
immunoglobulin G (IgG)–negative control (middle panels; grey). Phase-contrast images are shown in the lower panels. FITC, Fluorescein
isothiocyanate. Black bars = 20 μm. (B) Percentage of CD24+ cells in three independent NP-R and NP-nR clones. (C) CD marker scores for the
indicated cell lines: NP marker CD24, the hyaluronic acid receptor CD44 and the mesenchymal stem cell markers CD73, CD90 and CD105.
(D) Gangliosidase 2 (GD2) histograms of subconfluent cultures of representative NP subtypes in maintenance medium (Mmed): NP-R115 and NP-nR105
(top panels) and 7-day differentiated cultures in differentiation medium (Dmed) (bottom panels). The U-CH1 chordoma cell line was used as a reference.
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son, we measured GAG synthesis and the formation of
OH-pro groups in two sets of four independent clones,
with each set representing a distinct NP subtype. As nei-
ther the exact culture methods nor the optimal compos-
ition of Dmed have been established for NP cells, we
compared GAG and OH-pro formation in monolayer
cultures. In addition, this allowed comparison with data
collected to date for the current and other cell lines [14].
We found that, compared to NP-nR clones, NP-R clones
produced more (fourfold) GAGs in response to Dmed
(Figure 6A). In contrast, culture in Mmed for the same
amount of time did not induce GAG production in ei-
ther subtype (Figure 6A). Although the formation of
OH-pro was induced in both NP clonal subtypes in re-
sponse to Dmed, OH-pro levels reached significantly
higher values in NP-R than in NP-nR clones (Figure 6A);no OH-pro was detectable at baseline or in Mmed.
Thus, consistent with their distinctive responses to dif-
ferentiation conditions (for example, induction of SOX9
and COL2A1) (see Figure 4), NP-R clones produced
more GAGs and OH-pro than NP-nR.
We next tested the differentiation capacity of NP-R
and NP-nR cells on Matrigel, as this was recently shown
to support differentiation of induced pluripotent stem
cells (iPSCs) to NP-like cells [38]. In addition, we exam-
ined the effect of ACAN coating on NP subtype differ-
entiation. ACAN is an important constituent of the NP
ECM, and ACAN coating has been applied to assist dif-
ferentiation of meniscus-derived fibrochondrocytes and
MSCs into chondrocyte-like cells [39,40]. We cultured
NP-R and nR cells in the presence of either Matrigel or
ACAN for 3 to 7 days under differentiation conditions
and compared induction of SOX9, COL2A1, ACAN and
Figure 6 Extracellular matrix molecules in nucleus pulposus differentiation. (A) Extracellular matrix (ECM) properties in responsive nucleus
pulposus (NP-R) clones (left column; R) and nonresponsive nucleus pulposus (NP-nR) clones (right columns; nR). Sulphated glucosaminoglycan
(GAG; left graph) and hydroxyproline (right graph; OH-pro) quantities in four representative NP-R clones (108, 114, 115 and 124; grey circles) and
four NP-nR clones (102, 105, 113 and 119; black circles) at baseline (t = 0), at 7 days in differentiation medium (Dmed) and at 7 days in maintenance
medium (Mmed). Statistical significance was assessed by Student’s t-test. *P < 0.05; **P < 0.01; n.dct., Not detectable. Full list of P-values is
provided in Additional file 1: Table S3. (B) Comparison of marker expression on monolayer (mono; uncoated polystyrene), Matrigel-coated
(M.gel) and aggrecan- coated (ACAN) cultured NP cell clones. Gene expression levels of SRY-box 9 (SOX9), COL2A1, ACAN and cartilage oligomeric
matrix protein (COMP) are depicted. Grey bars correspond to NP-R115, and black bars to clone NP-nR105. Gene expression was normalized to β-ACTIN
mRNA levels. Data are expressed as fold changes relative to expression levels at baseline (t = 0) (Mmed). Statistical significance was assessed by
Student’s t-test. Full list of P-values is provided in Additional file 1: Table S4. *P < 0.05; **P < 0.01; n.dct. = not detectable. (C) Phase-contrast
images of representative NP-R clones and NP-nR clones on Matrigel-coated plates at 36 hours postplating. (D) Phase-contrast images of
representative NP-R clones and NP-nR clones on monolayer plastic or ACAN coating at 72 hours postplating. Black bars = 20 μm.
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conditions and was not induced (data not shown). SOX9
mRNA levels were comparable between the NP subtypes
under all conditions tested. Interestingly, COMP induction
was consistently higher in NP-R cells, whereas, conversely,
ACAN induction was consistently higher in NP-nR cells,
providing further support for the maintenance of dis-
tinct functional properties between the NP-R and NP-
nR clones. Only on Matrigel was COL2A1 induced
significantly greater in NP-R cells (Figure 6B). Remark-
ably, Matrigel and ACAN coating had dramatic effects
on differentiation-induced COMP and COL2A1 expres-
sion levels, respectively. These combined results sup-
port the idea that ECM is a determining factor in NPcell differentiation responses and suggest that distinct
NP cell types differentially respond to the presence of
ECM molecules.
The variation in differentiation capacity between NP-R
and NP-nR clones suggested a possible difference in differ-
entiation status or maturity between NP cellular subtypes.
As relatively immature porcine NC and NP cells were
shown to form spheroids on Matrigel [41], we compared
NP-R and NP-nR clones for their ability to form spheroids
structures under similar conditions. NP-R clones produced
spheroid structures on Matrigel, whereas growth of NP-nR
clones appeared to be restricted to small adherent colonies
(Figure 6C). Remarkably, on ACAN, the NP subtypes revealed
similar responses: NP-R clones showed poor attachment
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oid formation occurred within 24 hours and was most
prominent at 72 hours postplating. In contrast, NP-nR
clones maintained surface adherence, and spheroid forma-
tion (that is, adherence) appeared only sporadically (see,
for example, Figure 6D). These collective findings suggest
that distinct biological responses are triggered in NP sub-
types in the presence of ECM and that Matrigel and
ACAN evoke gene-specific transcriptional responses in
NP cells compared to standard monolayer differentiation
assay conditions.
Discussion
The application of human IVD material as a potential
source of cell lines to date has been limited. Sakai et al.
published their first immortalized HNPSV-1 cell line in
2004 [12]. The authors of a recent report [13] described
the generation of an NP cell line utilizing a distinct
immortalization strategy that we employed in our present
study. Despite the low number of studies in which investi-
gators have utilized immortalized NP cell lines, such
models provide valuable tools with which to study import-
ant aspects, such as the developmental origins of NP, NP
cell biology disc degeneration, and can also aid in drug de-
velopment and drug testing. In this report, we present the
generation and thorough initial characterization of novel
clonal human NP cell lines. We have established multiple
NP cell lines starting from immortalized primary (P5) NP
cultures derived from two independent donors. Import-
antly, analysis of immortal NP clones shows that multiple
clonal subtypes can be distinguished based on morpho-
logical characteristics, marker gene expression and their
diverse responses to differentiation conditions. We also
report that ECM-assisted culture models further segregate
the NP-R and nR phenotypes based on their spheroid-
forming capacity in culture.
Nucleus pulposus marker expression
Several reported NP markers expressed by our immortal
cell clones are consistent with a human NP phenotype
and hence distinguish our primary NP and AF cultures.
NP cell cultures typically synthesize COL2A1, ACAN
and SOX9, whereas AF cells predominantly produce
COL1A1 and considerably less COL2A1 [42]. Cytokera-
tin 8 (CK8) and cytokeratin 19 (KRT19) have been sug-
gested as potential NP markers [5,33,43]. Indeed, our
NP primary cultures clearly segregated from AF cultures
based on KRT19 mRNA expression. In line with the re-
port of cell surface marker CD24 being able to identify
the immature NP [44], we found CD24 expression in
primary NP cells. Although none of the markers used in
the present or previously published analyses are exclu-
sively linked to AF, NP or AC tissue, the consistency of
the quantitative differences we detected between AF-and NP-derived cultures further substantiates corres-
pondence to their tissue of origin.
We report here, for the first time to the best of our
knowledge, that the significant differences in marker ex-
pression between immortal NP subtypes isolated from
immortalized primary cultures (CA12, CD24, FOXF1,
PTN, PAX1 and COMP) discriminate human NP sub-
types from two independent donors in primary mono-
layer cultures. Relevantly, the CA12, CD24, FOXF1 and
KRT19 genes have been used successfully to study IVD-
like differentiation of MSCs [45]. Of note, throughout
the present study, we used differentiation conditions that
have previously been established for AC models. As the
most optimal conditions for NP cell differentiation are
currently unknown, some caution is warranted in direct
translation of this data to the in vivo situation. Likewise,
numerous animal studies have revealed NP markers that
either fail as human NP markers or have not been evalu-
ated in human IVD tissue. Thus, despite recent advances,
a consistent definition of a NP marker signature for hu-
man cells in vivo is currently lacking [7,46]. Investigators
in recent gene expression array studies have identified
additional markers that distinguish human NP cells from
AC and/or AF cells [3,5]. Similarly, gene expression ana-
lysis of distinctive immortalized cellular subtypes may
prove useful in refinement of NP marker definition and is
also expected to contribute to the development of robust
differentiation protocols. Clearly, additional functional
analyses are required to determine the role of NP markers
in the development and pathology of the IVD.
Nucleus pulposus cell models and differentiation
protocols
Using primary tissue from scoliosis patients as starting
material justifies the question whether the primary cul-
ture and the immortalized cell cultures may contain de-
generate cells. Although we cannot formally exclude this
possibility based on our marker analysis, the IVD mater-
ial we used for these studies was mainly obtained from
the convex (that is, noncompressed) side of scoliotic
discs. Of note, all available donors were relatively young.
In addition, although the number of studies on DDD in
the context of scoliosis are limited, DDD is rarely de-
tected at this age, with the exception of cases with asso-
ciated morbidity (for example, concurrent congenital
spinal stenosis, body mass index >30, athletics) [47].
It is important to note that the application of immortal
cell lines is restricted to in vitro analyses. Experimental
application may be limited as a direct consequence of
the immortalization procedure itself. For example, SV40LTag
interferes with pRB and TP53 function; both proteins
are involved in the programming of senescence, which
may be relevant for the degeneration process [48-52].
However, the establishment of distinct NP clonal phenotypes
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knowledge) provides access to a source of human NP
cell models that will enable us to exploit differences in
aspects such as cell surface marker expression to study
NP cell biology. These immortalized NP cell models
should thus be viewed as powerful complementary
models to primary isolates.
The identification of distinct cell phenotypes among
our immortalized NP cell clones reflects the cellular het-
erogeneity in vivo and provides important avenues for
further study. Our observations reported herein support
the notion that it is possible to fix different epigenetic
states (that is, functional cellular heterogeneity) in the
NP by means of immortalization procedures. Indeed,
others have observed that cellular phenotypes are retained
by immortalization [53]. It is relevant to note that NP-R
and NP-nR clonal outgrowth may have been subject to
selection bias, as integration of retroviral DNA is dependent
on active de novo DNA replication; as such, the hetero-
geneity in NP tissue may not be limited to the two sub-
types described herein.
Many differentiation protocols have been optimized
for SOX9, COL2A1 or GAG expression in AC cultures,
and such protocols have been used to differentiate bone
marrow– or adipose tissue–derived MSCs towards an
NP-like phenotype [54]. Also, TGFβ3 supplementation
reproducibly promotes collagen and GAG synthesis in
primary NP cells [31,55]; yet, the exact conditions that
faithfully support NP differentiation (and appropriately
functioning matrix formation) have been reported
throughout the literature to vary and thus appear not to
be fully optimized (a parameter that is dependent on
consensus definitions of NP phenotypes). Our observa-
tion that TGFβ3 repressed expression of novel NP
markers in primary cells and cell clones is consistent
with a recent report [45]. Coculture experiments
employing MSCs or conditioned media indicate that as
yet unknown factors contribute to NP differentiation and/
or phenotype stabilization [56-59]. The presence of Matri-
gel or ACAN produced a stronger induction of conven-
tional chondrogenic markers in our clonal NP cell lines.
Similarly, ACAN coating has been reported to induce a
chondrocyte-like phenotype in primary fibroblasts,
which upregulated COL2A1 and SOX9 but not ACAN,
and primary meniscus fibrochondrocytes induced
ACAN expression but not COL2A1 and SOX9 [19,39].
Also, bone marrow stromal cells express ACAN in re-
sponse to ACAN coating culture [40]. Remarkably, we
found that Matrigel and ACAN enhanced induction of
COMP and COL2A1 expression, respectively. Although
the mechanism by which ACAN affects differentiation
is currently unclear, it is possible that ACAN functions
to enhance growth factor signalling, as was recently
shown for COMP [60]. In this light, it would be ofinterest to determine the effect of ACAN coating on NP
phenotype stability. Clearly, a much improved definition
of NP maintenance and differentiation conditions is
needed.
Nucleus pulposus cellular subpopulations
Evidence for the existence of a progenitor population in
the adult human disc in vivo is accumulating [3,10,61,62].
The immature NP contains NCs that harbour stem cell–
like properties, and their lifelong presence in small labora-
tory animals, in contrast to humans, is thought to support
tissue repair and thus prevent disc degeneration [63,64].
NCs are replaced by smaller, rounded, chondrocyte-like
cells in early human adulthood [65]. As increasing evi-
dence points to an ontogenic relationship between the
notochord and the NP, [66], expression analysis of the NC
marker T was of relevance to pinpointing the exact nature
of our cell cultures. We found that T mRNA and T pro-
tein expression were very low and undetectable, respect-
ively, in the primary isolates from which the immortal
clones were derived. Only the primary NP isolate (D1P0)
from the youngest donor (8 years old) had detectable T
mRNA levels (Table 1). These data are consistent with
reports that T expression disappears during human IVD
maturation and is virtually undetectable from 10 years
of age onwards [7,67]. In keeping with this, the low or
absent T expression in our immortal clones suggests
that not NCs, but rather more mature NP cells, were
immortalized.
On the basis of their morphology and ability to induce
SOX9 and/or COL2A1 expression, we hypothesize that
our different immortalized subtypes may represent more
differentiated (NP-nR, cobblestone) or more progenitor-
like (NP-R, wavelike) cell types. Importantly, we found
both subtypes in two independent patient isolates (one
male, one female). Both subtypes were CD44+, CD73+,
CD90+ and CD105+, consistent with previously pub-
lished data [7]. CD24 and GD2 appeared to be more
prominently present in our NP-nR clones than in NP-R
clones, again supporting NP cell heterogeneity. Future
characterization is needed to ascertain the ontogeny of
the cloned cells.
The enhanced capacity to form spheroids under Matri-
gel and ACAN-supported culture conditions favours the
notion that the NP-R cells represent a more progenitor or
immature cell. Spheroid formation in culture is believed
to mirror stem and progenitor capacity in any cell popula-
tion. Lung-derived bronchospheres (or neurospheres, pan-
creatic) were previously shown to have stem cell– and
progenitor-like characteristics [68,69]. Indeed, spheroid
formation was also recently used to identify progenitor
cell presence in the IVD [10]. The NP-R and NP-nR
clones classify as GD2−/CD24− and GD2+/CD24+, respect-
ively, and the spheroid-forming capacity of a subset of
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ation map for Tie2, GD2 and CD24 [10]. Whether the
phenotypes (chondrocyte-like, spheroid-forming and/or
repopulating cells vs fibroblast-like cells) match our NP-R
and NP-nR phenotypes and what role they fulfil in human
NP development and disease remain to be determined. At
this point, it is also premature to speculate about the on-
togeny of these cells.Conclusions
We report, for the first time to the best of our knowledge,
the generation of phenotypically distinct immortal sub-
clones from primary human NP tissue. Characterization of
these clones suggests they correspond to discrete subpopu-
lations in the NP, which differ in terms of morphology, cell
surface NP marker expression and differentiation capacity.
Interestingly, AC cell lines generated in the 20th century
continue to provide important new insights into funda-
mental issues relating to AC cell biology [70]; thus, simi-
larly immortal NP cell lines are expected to provide vital
tools with which to study molecular mechanisms of NP cell
ontogeny and cell function in the healthy and diseased
IVD. It has become clear that the NP chondrocyte differs
from AC; yet, there is currently no comprehensive, descrip-
tive consensus regarding the NP phenotype. We advocate
a systematic analytical coverage of isolation procedures,
culture conditions and NP marker expression. The envir-
onmental interplay between chondrogenic factors and
ECM proteins provides clues for further research. How to
define the NP cell and how to faithfully mimic the NP
microenvironment in vitro remain crucial questions to be
resolved in the IVD field. Such issues will determine the
success of cell replacement therapy and/or tissue engineer-
ing approaches to treating DDD.Additional file
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